MaxCyte, Inc. MXCT
NASDAQ · United States · Health Technology
$1.07-0.02 (-1.83%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-12 | -0.08 | -0.09 | +11.1% | $7.27M | +11.8% | +12.1%$1.24→$1.39 |
| Q1 2026 | 2026-05-12 | -0.04 | -0.10 | +60.0% | — | — | +24.8%$0.82→$1.02 |
| Q4 2025 | 2026-03-24 | -0.06 | -0.08 | +25.0% | — | — | -8.9%$0.76→$0.69 |
| Q3 2025 | 2025-11-12 | -0.12 | -0.11 | -9.1% | — | — | -2.6%$1.55→$1.51 |
| Q4 2024 | 2025-03-11 | -0.10 | -0.12 | +16.7% | — | — | — |
| Q4 2023 | 2024-03-12 | -0.05 | -0.07 | +28.6% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.